Li Yumei, Wei Hongchang
Department of Pathology, College of Basic Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):470-5. doi: 10.1007/s11596-009-0416-6. Epub 2009 Aug 7.
To establish a stable and reliable model of refractory hypoxemia acute respiratory distress syndrome (ARDS) and examine its pathological mechanisms, a total of 144 healthy male Wistar rats were randomized into 4 groups: group I (saline control group), group II (LPS intravenous "single-hit" group), group III (LPS intratracheal "single-hit" group) and Group IV (LPS "two-hit" group). Rats were intravenously injected or intratracheally instilled with a large dose of LPS (10 mg/kg in 0.5 mL) to simulate a single attack of ARDS, or intraperitoneally injected with a small dose of LPS (1 mg/kg) followed by tracheal instillation with median dose of LPS (5 mg/kg) to establish a "two-hit" model. Rats in each group were monitored by arterial blood gas analysis and visual inspection for three consecutive days. Arterial blood gas values, lung wet/dry weight ratio and pathological pulmonary changes were analyzed to determine the effects of each ALI/ARDS model. Concentrations of TNF-alpha, IL-1 and IL-10 in the bronchoalveolar lavage fluid (BALF) and blood plasma were measured by using enzyme-linked immunosorbent assays (ELISA). Our results showed that single LPS-stimulation, whether through intravenous injection or tracheal instillation, could only induce ALI and temporary hypoxemia in rats. A two-hit LPS stimulation induces prolonged hypoxemia and specific pulmonary injury in rats, and is therefore a more ideal approximation of ARDS in the animal model. The pathogenesis of LPS two-hit-induced ARDS is associated with an uncontrolled systemic inflammatory response and inflammatory injury. It is concluded that the rat ARDS model produced by our LPS two-hit method is more stable and reliable than previous models, and closer to the diagnostic criteria of ARDS, and better mimics the pathological process of ARDS.
为建立稳定可靠的难治性低氧血症急性呼吸窘迫综合征(ARDS)模型并探讨其病理机制,将144只健康雄性Wistar大鼠随机分为4组:Ⅰ组(生理盐水对照组)、Ⅱ组(脂多糖静脉“单次打击”组)、Ⅲ组(脂多糖气管内“单次打击”组)和Ⅳ组(脂多糖“两次打击”组)。通过静脉注射或气管内滴注大剂量脂多糖(10 mg/kg溶于0.5 mL)模拟ARDS单次发作,或腹腔注射小剂量脂多糖(1 mg/kg)后气管内滴注中剂量脂多糖(5 mg/kg)建立“两次打击”模型。连续三天对每组大鼠进行动脉血气分析和肉眼观察监测。分析动脉血气值、肺湿/干重比及肺部病理变化以确定各急性肺损伤/ARDS模型的效果。采用酶联免疫吸附测定法(ELISA)检测支气管肺泡灌洗液(BALF)和血浆中肿瘤坏死因子-α、白细胞介素-1和白细胞介素-10的浓度。我们的结果表明,单次脂多糖刺激,无论是通过静脉注射还是气管内滴注,仅能诱导大鼠发生急性肺损伤和短暂性低氧血症。两次脂多糖刺激可诱导大鼠发生持续性低氧血症和特异性肺损伤,因此是动物模型中更理想的ARDS近似模型。脂多糖两次打击诱导的ARDS发病机制与失控的全身炎症反应和炎症损伤有关。结论是,我们采用的脂多糖两次打击法制备的大鼠ARDS模型比以往模型更稳定可靠,更接近ARDS诊断标准,能更好地模拟ARDS的病理过程。